Peptide and Anticoagulant Drugs Market – Key Players and their Growth
Increasing prevalence of chronic diseases and favorable government policies for the pharmaceutical sector are driving the growth of this market.
(businesspress24) - Indian Peptide Drugs Market
The Indian peptide drugs market is expected to reach USD 883.0 million by 2022 from USD 381.8 million in 2016, at a CAGR of 15.0%.
Increasing prevalence of chronic diseases and favorable government policies for the pharmaceutical sector are driving the growth of this market.
The Indian peptide drugs market is consolidated in nature with a large number of players. The Indian peptide drugs market is dominated by Abbott Laboratories (US), Sanofi S.A. (France), Eli Lilly and Company (US), Cipla Limited (India), and Biocon Limited (India), which together held a share of 68.2% in 2016. Other companies in the Indian peptide drugs market are Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited (India), Emcure Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Dr. Reddy
Download a PDF Brochure:-
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77044734
Indian anticoagulant drugs Market
The Indian anticoagulant drugs market is expected to reach USD 170.26 million by 2022 from USD 127.82 million in 2016, at a CAGR of 4.9%.
The growing incidence of coagulation disorders and government support for pharmaceutical companies are driving the growth of this market.
The Indian anticoagulant drugs market is also consolidated in nature. The Indian anticoagulant drugs market is dominated by Sanofi (France), Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Bharat Serum (India), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), and Lupin Ltd. (India), which together held a share of 68.6% of the market in 2016. Other players in this market include Dr. Reddyted for a combined share of 31.4% of the Indian anticoagulant drugs market in 2016.
Request Sample Pages:-
https://www.marketsandmarkets.com/requestsampleNew.asp?id=77044734
Themen in dieser Pressemitteilung:
peptide-and-anticoagulant-drugs-market
indian-peptide-drugs-market
indian-anticoagulant-drugs-market
indian-heparin-market
peptide-and-anticoagulant-drugs
anticoagulant-drugs-market
peptide-drugs-market
peptide-drugs
anticoagulant-drugs
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 12.12.2019 - 05:48 Uhr
Sprache: Deutsch
News-ID 1543161
Anzahl Zeichen: 2477
Kontakt-Informationen:
Ansprechpartner: Mr. Shelly Singh
Stadt:
northbrook
Telefon: 8886006441
Kategorie:
Gesundheitswesen - Medizin
Meldungsart: Produktinformation
Versandart: Veröffentlichung
Freigabedatum: 12.12.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 74 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Peptide and Anticoagulant Drugs Market – Key Players and their Growth
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
